Paperpal Prime Logo

Epilepsia Open : Impact Factor & More

eISSN: 2470-9239pISSN: 2470-9239
JournalOpen Access

Key Metrics

CiteScore
6.5
Impact Factor
< 5
SJR
Q2Neurology
SNIP
1.52
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Epilepsia Open

Epilepsia Open Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Quarterly
Article Processing ChargesUSD 2400
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorInternational League Against Epilepsy (ILAE)
FrequencyQuarterly
Publication Start Year2016
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Epilepsia Open ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Epilepsia Open

Management of Infantile Epileptic Spasms Syndrome: A survey of US pediatric hospitals.
  • 8 Aug 2026
  • Epilepsia open
Frequency of anti-neural antibodies and autoimmune epilepsy in focal epilepsy of unknown etiology: Anobservational study in a Singaporean cohort.
  • 8 Aug 2026
  • Epilepsia open
Neuroimaging of the ictal\u2013interictal continuum: Where do we stand? A systematic review and meta\u2010analysis of current evidence
  • 7 Aug 2026
  • Epilepsia Open
Sustained seizure reduction, treatment simplification, and high retention with cenobamate: A 12\u2010month real\u2010world study in refractory and ultra\u2010refractory focal epilepsy
  • 5 Aug 2026
  • Epilepsia Open
Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.
  • 3 Aug 2026
  • Epilepsia open
Astrocyte subtype-specific alterations in the dentate gyrus of individuals with mesial temporal lobe epilepsy.
  • 1 Aug 2026
  • Epilepsia open
Management of Infantile Epileptic Spasms Syndrome: A survey of US pediatric hospitals.
  • 8 Aug 2026
  • Epilepsia open
Frequency of anti-neural antibodies and autoimmune epilepsy in focal epilepsy of unknown etiology: Anobservational study in a Singaporean cohort.
  • 8 Aug 2026
  • Epilepsia open
Neuroimaging of the ictal\u2013interictal continuum: Where do we stand? A systematic review and meta\u2010analysis of current evidence
  • 7 Aug 2026
  • Epilepsia Open
Sustained seizure reduction, treatment simplification, and high retention with cenobamate: A 12\u2010month real\u2010world study in refractory and ultra\u2010refractory focal epilepsy
  • 5 Aug 2026
  • Epilepsia Open
Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.
  • 3 Aug 2026
  • Epilepsia open
Astrocyte subtype-specific alterations in the dentate gyrus of individuals with mesial temporal lobe epilepsy.
  • 1 Aug 2026
  • Epilepsia open

FAQs on Epilepsia Open